IN MENTAL HEALTH
Prescription digital therapeutics bridge the gap between treatment and everyday life
![Man walking on a partial mobile phone bridge](/us/pdt-pathway/sites/default/files/2024-04/man-walking-on-bridge.png)
Prescription digital therapeutics (PDTs) are software-based solutions prescribed by HCPs that deliver FDA-cleared, evidence-based therapy to patients through devices such as a smartphone or tablet1,2
The revolution of PDTs to deliver validated neurobehavioral techniques in mental health has begun. Treatments delivered via PDT have been clinically proven to help treat, manage, and prevent a spectrum of disease and disorders, including mental health conditions.1,2 PDTs have been proven efficacious in the real world for a range of behavioral health conditions, including ADHD, anxiety, depression, insomnia, PTSD, and substance abuse.3
PDTs are distinctly different from health and wellness apps because they are1:
![A graph showing an incline A graph showing an incline](/us/pdt-pathway/sites/default/files/2023-08/graph-with-incline1.png)
Rigorously studied for safety and efficacy in randomized clinical trials
![FDA-Cleared Icon FDA-Cleared Icon](/us/pdt-pathway/sites/default/files/2024-04/fda-cleared-icon.png)
Cleared by the FDA*
![RX logo RX logo](/us/pdt-pathway/sites/default/files/2023-08/RX-logo.png)
Prescribed by health care providers
*While drugs are “approved” by the FDA, PDTs are FDA “authorized” or cleared as a software as a medical device (SaMD). All of them are required to have clinical trials as part of the FDA authorization.4
![CT-155-chart CT-155-chart](/us/pdt-pathway/sites/default/files/2024-04/CT-155-chart-min_2.png)
Three different ways to use PDTs5,6
Expand All
Individual, and in some cases, independent of other therapies. Can also be used at the same time as other treatments.
Concomitant with pharmacological intervention.
Works in combination with pharmacological and nonpharmacological interventions by complementing self-management of condition and related health care factors.
PDTs are a treatment modality that can be incorporated into a multimodal treatment approach and may be effective independently or as an adjunct to medication, devices, or psychotherapy.2 This offers the potential to increase access to care, expand treatment options, and improve health equity1
NOTES:
1. If you need more space to make the copy fit, then you can remove the image.
2. superscript the 1,2
![A woman holding a phone A woman holding a phone](/us/pdt-pathway/sites/default/files/2024-04/Woman-holding-a-phone.png)
Addressing the gaps in mental health:
Getting patients care where and when they need it1,2
With PDTs, patients with mental health conditions can access treatment anytime, anyplace,
which can help relieve the barriers to comprehensive care, such as:
![Icons of people with thoughts Icons of people with thoughts](/us/pdt-pathway/sites/default/files/2023-08/icons-of-people-with-thoughts.png)
Stigma1
![A heart and a lock icon A heart and a lock icon](/us/pdt-pathway/sites/default/files/2023-08/Heart-and-lock-icon.png)
Poor access to care1,2
![An icon of a doctor An icon of a doctor](/us/pdt-pathway/sites/default/files/2023-08/icon-of-a-doctor.png)
Provider shortages1
![Three squiggly arrows crossing each other Three squiggly arrows crossing each other](/us/pdt-pathway/sites/default/files/2023-08/three-squiggly-arrows-crossing-each-other.png)
Complex health systems1
Empowering patients to take an active role in their care2,5,7-9
Some of the ways PDTs empower patients in mental health include:
Self-directed training sessions5
Treatment reminders, education, and individualized dosing calculations7
Data capture and health information analyzation2
Behavior-modifying game play8
Progress tracking and goal setting/achievement9
![A man using a mobile phone A man using a mobile phone](/us/pdt-pathway/sites/default/files/2024-04/a-man-using-a-mobile-phone.png)
PDTs are designed to be convenient and user friendly, expanding accessibility to evidence-based treatments anytime, anywhere1,2
How can PDTs fit into your treatment approach?
![PDT promo for extension of care PDT promo for extension of care](/us/pdt-pathway/sites/default/files/2024-04/pdt-promo-graphic-one_0.png)
An extension of care for patients between visits5
Incorporating PDTs can enable healthcare providers and patients to extend their current practices between visits, enhancing patient care and outcomes.
![PDT promo for effective independently PDT promo for effective independently](/us/pdt-pathway/sites/default/files/2023-08/pdt-promo-graphic-two.png)
Effective independently or as an adjunct to medications, devices, or psychotherapy1,2
Offering the potential to increase access to care, expand treatment options, and improve health equity.
![PDT promo for expand accessibility PDT promo for expand accessibility](/us/pdt-pathway/sites/default/files/2023-08/pdt-promo-graphic-three.png)
Expand accessibility to evidence-based treatments for certain disease states1,5
Working in concert with remote education, assessment, and telehealth visits to further enable a holistic approach to care.
![PDT promo for low risk PDT promo for low risk](/us/pdt-pathway/sites/default/files/2024-04/pdt-promo-graphic-four.png)
Relatively low risk of adverse events5,10,11
People treated with PDTs are less likely to experience adverse events or drug interactions.
![PDT promo for designed to be convenient and user friendly PDT promo for designed to be convenient and user friendly](/us/pdt-pathway/sites/default/files/2024-04/pdt-promo-graphic-five_0.png)
Designed to be convenient and user friendly1,2
Patients can discreetly access validated neurobehavioral techniques delivered by PDTs anyplace, anytime.
Clinical trials are currently underway to explore the benefit of using PDTs for mental health conditions—paving the way for these technologies to help even more people receive the care they need to lead more fulfilling lives.3
Our commitment to changing the landscape of mental health care covers
a range of serious mental health conditions. Boehringer Ingelheim is
proud to partner with Click Therapeutics to investigate the applications of
PDTs in addressing gaps in care for those with serious mental health
conditions.
With PDTs, we are bringing innovative treatment modalities to people
living with serious mental health conditions so that they can create
more meaningful connections to their lives, loved ones, and society.
References
- Brezing CA, Brixner DI. The rise of prescription digital therapeutics in behavioral health. Adv Ther. 2022;39(12):5301-5306. doi:10.1007/s12325-022-02320-0
- Dang A, Arora D, Rane P. Role of digital therapeutics and the changing future of healthcare. J Family Med Prim Care. 2020;9(5):2207-2213. doi:10.4103/jfmpc.jfmpc_105_20
- What is digital health? American Psychological Association. Updated December 2023. Accessed March 28, 2024. https://www.apa.org/practice/digital-therapeutics-mobile-health
- Watson A, Chapman R, Shafai G, Maricich YA. FDA regulations and prescription digital therapeutics: evolving with the technologies they regulate. Front Digit Health. 2023;5:1086219. doi:10.3389/fdgth.2023.1086219
- Liesch J, Murphy D. Digital Therapeutics 101: An Introduction and Overview. Blue Matter Consulting. Published 2021. Accessed March 13, 2024. https://bluematterconsulting.com/wp-content/uploads/2021/06/Digital-Therapeutics-101-eBook-06-2021.pdf
- Kutz J, Culjat M, Averback J, Fujimoto C, Pecoraro J. Harnessing the commercial promise of prescription drug use-related software (PDURS). Eversana. March 7, 2024. Accessed April 30, 2024. https://www.eversana.com/insights/harnessing-pdurs/
- Unnikrishnan AG, Viswanathan V, Zhou FL, et al. Impact of My Dose Coach app frequency of use on clinical outcomes in type 2 diabetes. Diabetes Ther. 2022;13(5):983-993. doi:10.1007/s13300-022-01245-9
- EndeavorRx. Instructions for use. Akili Interactive Labs, Inc.; 2023.
- Jacobson NC, Kowatsch T, Marsch LA. Digital therapeutics for mental health and addiction: The state of the science and vision for the future. Elsevier Inc.; 2022.
- Wang C, Lee C, Shin H. Digital therapeutics from bench to bedside. NPJ Digit Med. 2023;6(1):38. doi:10.1038/s41746-023-00777-z
- Lutz J, Offidani E, Taraboanta L, Lakhan SE, Campellone TR. Appropriate controls for digital therapeutic clinical trials: a narrative review of control conditions in clinical trials of digital therapeutics (DTx) deploying psychosocial, cognitive, or behavioral content. Front Digit Health. 2022;4:823977. doi:10.3389/fdgth.2022.823977